Skip to content


Oxtellar, Trileptal (oxcarbazepine) is a small molecule pharmaceutical. Oxcarbazepine was first approved as Oxtellar on 2000-01-14. It is used to treat epilepsy and partial epilepsies in the USA. Trileptal's patent is valid until 2027-04-13 (FDA).
Trade Name Oxtellar, Trileptal
Common Name Oxcarbazepine
Indication epilepsy, partial epilepsies
Drug Class Tricyclic compounds
Get full access now